
Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

China should adopt a structure-function claims system similar to what exists in the United States, USCHPA says.

Beginning in December, EU manufacturers must call out allergens such as celery on ingredient lists.

Two industry leaders offer advice to the next head of FDA’s Division of Dietary Supplements-whoever she or he may be.

Up to 5% of products are currently in danger of non-compliance, says FDA.

David Kessler, MD, says there's no reason for ingredient labels to be confined to the sides and backs of products.

Choosing the right testing techniques while still keeping an eye on the bottom line.

Businesses may need to alter their practices to stay within the new lines set by the WHO and FAO's Codex Alimentarius Commission.

Missouri children with epileptic seizures can now use hemp CBD extracts when other treatments don't work.

Will the current push for sex-specific analysis in pharma research inspire changes for dietary supplements, too?

USCHPA reported that on July 1, China’s National People’s Congress passed draft reform of China’s Food Safety Law.

The agreement makes importing and exporting of organic products easier for both countries.

The announcement comes includes new dietary reference intakes for EPA and DHA, as well as special recommendations of DHA for certain populations.

The FTC announced today that L’Oréal USA has agreed to settle charges over advertisements for Lancôme Génifique and L’Oréal Paris Youth Code skincare products.

More than 70 representatives of the dietary supplements industry met with members of Congress this week as part of CRN's "Day on the Hill."

A French government report raised questions about meso-zeaxanthin safety and sparked renewed debate over zeaxanthin isomers.

Companies can apparently sue over labels that are FDA compliant. But it could be worse.

This is the first NDI notification for an omega-3 ingredient derived from the microalgae species Nannochloropsis oculata.

Yesterday’s State Legislature vote was close (7-8).

It's not FTC action alone.

Domestic hemp scored several victories around the same time the DEA seizes a shipment of hemp imports.

Dr. Oz said he is "second-guessing" the way he presents weight-loss supplements on his television show.

The American Herbal Products Association observed these recent numbers as it updated its AHPA NDI database.

Does this ruling open opportunities for companies to sue over food labels already compliant with FDA’s Food, Drug and Cosmetic Act?

One Commissioner calls FTC’s requirements “unduly high."

The good news? China is considering making major changes to its regulatory process.

If passed by the State Assembly in the coming months, the bill could mandate warnings on drinks with added sugars.

Lawsuits abound due to lack of a formal regulatory definition for "natural" and "all natural."